Neoplasie prostatiche, resistenti alla castrazione的临床试验
总计106147个结果
-
Dana-Farber Cancer InstituteProgenics Pharmaceuticals, Inc.尚未招聘前列腺癌 | 转移性去势抵抗性前列腺癌 | 转移性去势抵抗性前列腺癌美国
-
Sheffield Teaching Hospitals NHS Foundation TrustSheffield Hallam University未知
-
Rohan GarjeJanssen Scientific Affairs, LLC尚未招聘
-
Sumitomo Pharma Switzerland GmbH主动,不招人
-
Jiangnan UniversityAffiliated Hospital of Jiangnan University完全的
-
Shanghai Changzheng HospitalBioray Laboratories招聘中
-
National Cancer Institute, Naples主动,不招人
-
Michael Graham PhD, MDUniversity of Iowa; Holden Comprehensive Cancer Center完全的
-
Michael Graham PhD, MDUniversity of Iowa; Holden Comprehensive Cancer Center主动,不招人
-
Leiden University Medical CenterAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Anticancer Fund, Belgium招聘中
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKline; University of Washington完全的
-
Jiangnan UniversityAffiliated Hospital of Jiangnan University招聘中
-
Memorial Sloan Kettering Cancer CenterCelgene Corporation完全的
-
Astellas Pharma Europe B.V.Medivation, Inc.完全的
-
Modra PharmaceuticalsThe Netherlands Cancer Institute完全的
-
Taro Iguchi, MD, PHDAstellas Pharma Inc完全的
-
Novartis Pharmaceuticals完全的
-
Tulane UniversityBlue Earth Diagnostics完全的
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.未知转移性去势抵抗性前列腺癌
-
Gustave Roussy, Cancer Campus, Grand ParisSanofi未知
-
The Christie NHS Foundation TrustAstraZeneca完全的
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLC招聘中